Cleared Traditional

K202694 - Vycor Medical Viewsite Brain Access System (“VBAS”) and VBAS with Alignment Clip (“VBAS AC”) (together the “VBAS Family”) (FDA 510(k) Clearance)

Jan 2021
Decision
120d
Days
Class 2
Risk

K202694 is an FDA 510(k) clearance for the Vycor Medical Viewsite Brain Access System (“VBAS”) and VBAS with Alignment Clip (“VBAS AC”) (together the “VBAS Family”). This device is classified as a Retractor, Self-retaining, For Neurosurgery (Class II - Special Controls, product code GZT).

Submitted by Vycor Medical, Inc. (Boca Raton, US). The FDA issued a Cleared decision on January 14, 2021, 120 days after receiving the submission on September 16, 2020.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.4800.

Submission Details

510(k) Number K202694 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 16, 2020
Decision Date January 14, 2021
Days to Decision 120 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code GZT - Retractor, Self-retaining, For Neurosurgery
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.4800